Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin vs Ergometrin for PPH Prevention in C-Section
NCT04300452Phase 4Unknown
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Apr 2018
- Primary completion
- Jun 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by National and Kapodistrian University of Athens. Primary endpoints: Hemoglobin at 24 hours, Hematocrit at 24 hours and 1 more. Status: unknown.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT04300452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04300452.